| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/31/2011 | US20110077308 Agonists of Bitter Taste Receptors and Uses Thereof |
| 03/31/2011 | US20110077283 Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases |
| 03/31/2011 | US20110077210 Hdac regulation assays, compounds and therapeutic compositions |
| 03/31/2011 | US20110077168 Methods for distinguishing between specific types of lung cancers |
| 03/31/2011 | US20110077162 Analytical measuring and evaluation method for molecular interactions |
| 03/31/2011 | US20110076783 Multi-dimensional fluid sensors and related detectors and methods |
| 03/31/2011 | US20110076782 Read-after-write detection of analytes via nanoparticle-labeled substances |
| 03/31/2011 | US20110076781 Expanding the dynamic range of a test strip |
| 03/31/2011 | US20110076778 Solubilization of proteins in reverse micelles by extraction from a solid support |
| 03/31/2011 | US20110076777 Reaction apparatus and process |
| 03/31/2011 | US20110076776 Methods, system and devices for analyzing a biological fluid sample following ion exchange |
| 03/31/2011 | US20110076775 Methods, systems and devices for analyzing a surfactant-treated biological fluid sample |
| 03/31/2011 | US20110076774 Sample analyzer and sample analyzing method |
| 03/31/2011 | US20110076763 Neoplasm specific antibodies and uses thereof |
| 03/31/2011 | US20110076735 Microfluidic Devices |
| 03/31/2011 | US20110076730 Microbial synthesis of d-1,2,4-butanetriol |
| 03/31/2011 | US20110076711 Photon reducing agents for fluorescence assays |
| 03/31/2011 | US20110076708 Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions |
| 03/31/2011 | US20110076705 Compositions and methods for early pregnancy diagnosis |
| 03/31/2011 | US20110076704 Method for diagnosing alzheimer's disease using serum glycoprotein as biomarker |
| 03/31/2011 | US20110076703 Concentration assay |
| 03/31/2011 | US20110076702 Recombinant 12-kda protein useful for the detection of respiratory allergies |
| 03/31/2011 | US20110076701 Multi-stage nutrigenomic diagnostic food sensitivity testing in animals |
| 03/31/2011 | US20110076700 Anti-crp antibody and utilization of the same |
| 03/31/2011 | US20110076699 Hemolysin and its protein fragments in sero-detection of anaplasma phagocytophilum |
| 03/31/2011 | US20110076698 method of quickly determining human abo/rh/mn blood type and a test kit thereof |
| 03/31/2011 | US20110076697 Lateral-flow immuno-chromatographic assay devices |
| 03/31/2011 | US20110076696 Cardiovascular safety assay |
| 03/31/2011 | US20110076695 Immunoassay analyzer and immunoassay method |
| 03/31/2011 | US20110076694 Method of assessing mammalian embryo quality |
| 03/31/2011 | US20110076693 Method for detection and quantification of plk1 expression and activity |
| 03/31/2011 | US20110076692 Detection of Cardiac Markers on a Droplet Actuator |
| 03/31/2011 | US20110076691 Two step lateral flow assay methods and devices |
| 03/31/2011 | US20110076688 Method for enumeration of mammalian micronucleated erythrocyte populations, while distinguishing platelets and/or platelet-associated aggregates |
| 03/31/2011 | US20110076684 Apparatus and method for acquiring, detecting, and analyzing cells in a microfluidic system |
| 03/31/2011 | US20110076683 Identification, Isolation and Elimination of Cancer Stem Cells |
| 03/31/2011 | US20110076680 Fluorescent molecule |
| 03/31/2011 | US20110076670 Detection of analytes via nanoparticle-labeled substances with electromagnetic read-write heads |
| 03/31/2011 | US20110076301 Antigenic protein fragments of streptococcus pneumoniae |
| 03/31/2011 | US20110076296 TLR3 Agonist Compositions |
| 03/31/2011 | US20110076289 Transgenic animal model of neurodegenerative disorders |
| 03/31/2011 | US20110076287 Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods |
| 03/31/2011 | US20110076286 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
| 03/31/2011 | US20110076281 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders |
| 03/31/2011 | US20110076280 Dkk1 oncogene as therapeutic target for cancer and a diagnosing marker |
| 03/31/2011 | US20110076277 Methods of identifying anti-inflammatory compounds |
| 03/31/2011 | US20110076274 Materials and methods relating to a g-protein coupled receptor |
| 03/31/2011 | US20110076267 Humanized antibody compositions and methods for binding lysophosphatidic acid |
| 03/31/2011 | US20110076265 Monoclonal antibodies having homosubtype cross-neutralization properties against influenza a viruses subtype h1 |
| 03/31/2011 | US20110076259 Detection of risk of pre-eclampsia |
| 03/31/2011 | US20110076236 Compositions and methods of treatment using modulators of motoneuron diseases |
| 03/31/2011 | US20110076199 Device for the photometric examination of samples |
| 03/31/2011 | US20110076197 Nano-fibered membrane for western blot and manufacturing method of the same |
| 03/31/2011 | US20110076196 Photochemical reactor, luminescent screen and photochemical processing system |
| 03/31/2011 | US20110074452 Device for evaluating degree of degradation of lubricating oil |
| 03/31/2011 | US20110073493 Adhesive Composition for Use in an Immunosensor |
| 03/31/2011 | US20110072978 Method and Apparatus for Determining Taste Degradation of Coffee under Thermal Load |
| 03/31/2011 | US20110072960 Armor shielding |
| 03/31/2011 | US20110072889 Bcr-abl truncation mutations |
| 03/31/2011 | US20110072884 Personal breathalyzer having digital circuitry |
| 03/31/2011 | US20110072883 Multifunctional control valve for gas measurement instruments |
| 03/31/2011 | DE102010008066B3 Buchholzrelais Buchholz relay |
| 03/31/2011 | DE102009047807A1 Vorrichtung und Verfahren zum Detektieren mindestens einer Substanz Apparatus and method for detecting at least one substance |
| 03/31/2011 | DE102009047801A1 Durchflusskammer mit Zellleiteinrichtung Flow chamber with Zellleiteinrichtung |
| 03/31/2011 | DE102009043537A1 Verfahren und Anordnung zur Bestimmung von Zell-Vitalitäten Method and apparatus for determining cell viabilities |
| 03/31/2011 | DE102009043222A1 Verfahren zur Optimierung der Gaskonversionsrate in einem Atemgasanalysator Method for optimizing the gas conversion rate in a respiratory gas |
| 03/31/2011 | DE102009040880A1 Vorrichtung zur Durchführung von Tests zur Hämostase Device for carrying out tests for hemostasis |
| 03/31/2011 | CA2775324A1 Passivated nanoparticles |
| 03/31/2011 | CA2775322A1 Preparation of restriction endonucleases in ivcs using fret and facs selection |
| 03/31/2011 | CA2775291A1 Methods, compositions, and kits for reducing anti-antibody responses |
| 03/31/2011 | CA2775231A1 Systems and methods for measuring translation of target proteins in cells |
| 03/31/2011 | CA2775033A1 Method for the diagnosis of non-alcoholic steatohepatitis based on a metabolomic profile |
| 03/31/2011 | CA2774836A1 Antagonists of dsg2 for treatment of cancer |
| 03/31/2011 | CA2774615A1 Protein arrays and uses thereof |
| 03/31/2011 | CA2774576A1 Method of contaminant prediction |
| 03/31/2011 | CA2774555A1 Immunodiffusion assay for influenza virus |
| 03/31/2011 | CA2772945A1 Screening methods |
| 03/31/2011 | CA2771923A1 Process analysis unit |
| 03/30/2011 | EP2302395A1 Markers associated with arteriovascular events and methods of use thereof |
| 03/30/2011 | EP2302394A1 Compositions and methods for quantification of serum glycoproteins |
| 03/30/2011 | EP2302393A1 Compositions and methods for quantification of serum glycoproteins |
| 03/30/2011 | EP2302392A1 Novel AS160-like protein, test systems, methods and uses involving it for the identification of diabetes type 2 therapeutics |
| 03/30/2011 | EP2302391A1 Therapeutic and diagnostic uses of antibody specificity profiles in rheumatoid arthritis |
| 03/30/2011 | EP2302390A1 Methods for detecting and analyzing n-glycolylneuraminic acid (Neu5Gc) specific antibodies in biological materials |
| 03/30/2011 | EP2302389A1 Device and method for pressure-driven plug transport and reaction |
| 03/30/2011 | EP2302388A1 COP1 molecules and uses thereof |
| 03/30/2011 | EP2302387A1 Therapeutic and diagnostic uses of antibody specificity profiles for insulin-dependent diabetes mellitus |
| 03/30/2011 | EP2302386A1 Hydrophilic, high protein binding, low fluorescence, western blotting membrane |
| 03/30/2011 | EP2302385A1 Methods for selecting treatment regimens and predicting outcomes in cancer patients |
| 03/30/2011 | EP2302384A1 Method for carrying out a qualitative preliminary instant diagnosis of oncological diseases |
| 03/30/2011 | EP2302383A2 Docetaxel conjugates and immunogens for use in an immunoassay |
| 03/30/2011 | EP2302382A2 Docetaxel conjugates and immunogens for use in an immunoassay |
| 03/30/2011 | EP2302381A1 Gene signature for replicative senescence in cell cultures |
| 03/30/2011 | EP2302380A1 Method for preclinical testing of immunomodulatory drugs |
| 03/30/2011 | EP2302379A1 Methods and compositions for risk stratification |
| 03/30/2011 | EP2302378A2 Blood cell counter, diagnosis support method and computer program product |
| 03/30/2011 | EP2302377A2 Blood cell counter, diagnosis support method, and computer program product |
| 03/30/2011 | EP2302376A1 Electrochemical sensor for determining an analyte concentration |
| 03/30/2011 | EP2302375A1 Method and device for recording the current voltage curve of a cell |
| 03/30/2011 | EP2302373A1 Geomorphology for environmental remediation processes and systems |